Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6361-6377
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6361
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6361
Figure 4 P-selectin glycoprotein ligand 1 deficiency attenuates the number of circulating leukocytes.
A: Flow cytometry for CD45-positive cells to detect immune cells in the serum; B: Flow cytometry for CD11b-positive cells to detect myeloid cells in the serum; C: Boxplots showing quantification of immune cells in the serum (n = 4); D: Boxplots showing quantification of myeloid cells in the serum (n = 4); E: Flow cytometry for Ly-6G-positive cells and Ly-6C-positive cells to detect neutrophils and monocytes, respectively, in the serum; F: Boxplots showing quantification of neutrophils in the serum (n = 4); G: Boxplots showing quantification of monocytes in the serum (n = 4). aP < 0.05; bP < 0.01, cP < 0.001, Student's t-test. PSGL-1: P-selectin glycoprotein ligand 1; WT: Wild type; AP: Acute pancreatitis.
- Citation: Zhang X, Zhu M, Jiang XL, Liu X, Liu X, Liu P, Wu XX, Yang ZW, Qin T. P-selectin glycoprotein ligand 1 deficiency prevents development of acute pancreatitis by attenuating leukocyte infiltration. World J Gastroenterol 2020; 26(41): 6361-6377
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6361.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6361